Departments of Neurological Surgery.
Medicine.
Spine J. 2021 Dec;21(12):2026-2034. doi: 10.1016/j.spinee.2021.06.014. Epub 2021 Jun 20.
There is growing interest among payers in profiling hospital value and quality-of-care, including both the cost and safety of common surgeries, such as lumbar fusion. Nonetheless, there is sparse evidence describing the statistical reliability of such measures when applied to lumbar fusion for spondylolisthesis.
To evaluate the reliability of 90-day inpatient hospital costs, overall complications, and rates of serious complications for profiling hospital performance in lumbar fusion surgery for spondylolisthesis.
STUDY DESIGN/SETTING: Data for this analysis came from State Inpatient Databases from nine states made available through the Healthcare Cost and Utilization Project.
Patients undergoing elective lumbar spine fusion for spondylolisthesis from 2010 to 2017 in participating states.
Statistical reliability, defined as the ability to distinguish true performance differences across hospitals relative to statistical noise. Reliability was assessed separately for 90-day inpatient costs (standardized across years to 2019 dollars), overall complications, and serious complication rates.
Statistical reliability was measured as the amount of variation between hospitals relative to the total amount of variation for each measure. Total variation includes both between-hospital variation ("signal") and within-hospital variation ("statistical noise"). Thus, reliability equals signal over (signal plus noise) and ranges from 0 to 1. To adjust for differences in patient-level risk and procedural characteristics, hierarchical linear and logistic regression models were created for the cost and complication outcomes. Random hospital intercepts were used to assess between-hospital variation. We evaluated the reliability of each measure by study year and examined the number of hospitals meeting different thresholds of reliability by year.
We included a total of 66,571 elective lumbar fusion surgeries for spondylolisthesis performed at 244 hospitals during the study period. The mean 90-day hospital cost was $30,827 (2019 dollars). 12.0% of patients experienced a complication within 90 days of surgery, including 7.8% who had a serious complication. The median reliability of 90-day cost ranged from 0.97to 0.99 across study years, and there was a narrow distribution of reliability values. By comparison, the median reliability for the overall complication metric ranged from 0.22 to 0.44, and the reliability of the serious complication measure ranged from 0.30 to 0.49 across the study years. At least 96% of hospitals had high (> 0.7) reliability for cost in any year, whereas only 0-9% and 0-11% of hospitals reached this cutoff for the overall and serious complication rate in any year, respectively. By comparison, 10%-69% of hospitals per year achieved a more moderate threshold of 0.4 reliability for overall complications, compared to 21%-80% of hospitals who achieved this lower reliability threshold for serious complications.
90-day inpatient costs are highly reliable for assessing variation across hospitals, whereas overall and serious complications are only moderately reliable for profiling performance. These results support the viability of emerging bundled payment programs that assume true differences in costs of care exist across hospitals.
支付方越来越关注医院的价值和医疗质量,包括常见手术(如腰椎融合术)的成本和安全性。然而,当应用于腰椎融合术治疗脊椎滑脱症时,描述此类措施的统计可靠性的证据很少。
评估 90 天住院医院成本、总体并发症和严重并发症发生率在腰椎融合术治疗脊椎滑脱症中用于评估医院绩效的可靠性。
研究设计/设置:本分析的数据来自九个州的州际住院数据库,通过医疗保健成本和利用项目提供。
2010 年至 2017 年在参与州接受择期腰椎融合术治疗脊椎滑脱症的患者。
统计可靠性,定义为相对于统计噪声区分医院之间真实绩效差异的能力。可靠性分别针对 90 天住院费用(按 2019 年美元标准化)、总体并发症和严重并发症发生率进行评估。
统计可靠性通过测量每个指标的医院间变异与总变异之间的比例来衡量。总变异包括医院间变异(“信号”)和医院内变异(“统计噪声”)。因此,可靠性等于信号除以(信号加噪声),范围从 0 到 1。为了调整患者水平风险和手术特征的差异,为成本和并发症结果创建了分层线性和逻辑回归模型。随机医院截距用于评估医院间变异。我们通过研究年份评估了每个指标的可靠性,并检查了每年符合不同可靠性阈值的医院数量。
我们共纳入了 66571 例在研究期间在 244 家医院接受腰椎融合术治疗脊椎滑脱症的择期手术。90 天医院平均费用为 30827 美元(2019 年美元)。12.0%的患者在手术后 90 天内发生并发症,其中 7.8%的患者发生严重并发症。90 天成本的中位数可靠性在研究年内从 0.97 到 0.99 不等,可靠性值分布较窄。相比之下,总体并发症指标的中位数可靠性在研究年内从 0.22 到 0.44 不等,严重并发症指标的可靠性从 0.30 到 0.49 不等。在任何一年中,至少有 96%的医院在成本方面具有高(>0.7)可靠性,而在任何一年中,只有 0-9%和 0-11%的医院达到了整体和严重并发症发生率的这一截止值。相比之下,每年有 10%-69%的医院达到了整体并发症的 0.4 可靠性的中等阈值,而每年有 21%-80%的医院达到了严重并发症的这一较低可靠性阈值。
90 天住院费用对于评估医院间的差异非常可靠,而总体并发症和严重并发症仅在一定程度上可靠,用于分析绩效。这些结果支持新兴的捆绑支付计划的可行性,这些计划假设医院之间确实存在护理成本的差异。